Classic case of fib level retracements
Target 1: $140
Target 2: $150
Target 3: $160
There are resistance levels to break between the targets.
RSI and MACD suggest there's energy to break towards target #3 prior to earnings.
Considering PEG, future outlook, product pipeline, news storyline and environment - MRNA has a good potential for 2021.
Earnings call will be critical milestone.
Target 1: $140
Target 2: $150
Target 3: $160
There are resistance levels to break between the targets.
RSI and MACD suggest there's energy to break towards target #3 prior to earnings.
Considering PEG, future outlook, product pipeline, news storyline and environment - MRNA has a good potential for 2021.
Earnings call will be critical milestone.
